Production (Stage)
Medicale Corp.
MCLE
$0.1734
$0.01147.04%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 46.10K | 50.40K | 54.70K | 53.40K | 52.60K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 200.00 | -- | -- | -- | -- |
Total Operating Expenses | 46.20K | 50.40K | 54.70K | 53.40K | 52.60K |
Operating Income | -46.20K | -50.40K | -54.70K | -53.40K | -52.60K |
Income Before Tax | -52.40K | -55.70K | -58.30K | -55.60K | -53.60K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.05 | -0.06 | -0.06 | -0.06 | -0.05 |
Earnings from Discontinued Operations | -- | -- | -- | 0.00 | 0.00 |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -52.40K | -55.70K | -58.30K | -55.60K | -53.60K |
EBIT | -46.20K | -50.40K | -54.70K | -53.40K | -52.60K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Average Basic Shares Outstanding | 23.68M | 23.68M | 23.68M | 23.68M | 23.68M |
Average Diluted Shares Outstanding | 23.68M | 23.68M | 23.68M | 23.68M | 23.68M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |